Dr Lynette Waring
BSc, MBBS, FRCPA
Specialty
Microbiology
Phone number
03 9287 7475
After graduating from the University of Western Australia in 1985 and upon completion of her internship, Dr Waring commenced two years of paediatric training, followed by training in Medical Microbiology at the Fairfield Infectious Diseases and Royal Children’s Hospitals in Melbourne.
She was then admitted to an Infectious Diseases Fellowship at Stanford University Medical School in the United States for another two years. Following this she received her FRCPA.
Upon returning to Melbourne, Dr Waring completed 18 months of research at WEHI on DNA vaccines, before being appointed Medical Microbiologist at Dorevitch Pathology where she remained for the next seven years.
Dr Waring then moved to California where she worked in biotechnology companies for four years. She designed, established and monitored clinical trials of inhaled tobramycin, and worked on the development of a meningococcal Gp B vaccine. Most recently Dr Waring was the Director of Clinical Research and Medical Affairs for Microbiology for Roche Molecular Systems working on the development of new molecular diagnostic tests for microbiology.
Dr Waring returned to Australia in 2008 and was appointed Medical Microbiologist at the Princess Margaret Hospital for Children and at the King Edward Memorial Hospital for Women in Perth where she was actively involved in infection control, research into vaccine development and in clinical work including the diagnosis and management of neonatal, paediatric, oncology and maternal infections.
Dr Waring returned to Melbourne with her family early in 2010 and joined Melbourne Pathology in February. She brings a wealth of knowledge, experience and enthusiasm to the Microbiology Department and to the practice in addition to her passion for improving the diagnosis and management of infectious diseases in the wider community.